SAN DIEGO--(BUSINESS WIRE)--Michael Nova, M.D., Pathway Genomics’ chief medical officer, is scheduled to participate in a panel discussion focusing on the convergence of genomic and digital technology, and the impact it will have – and is having – on the ways in which health care is delivered. Sponsored by CommNexus, a forward-thinking non-profit technology industry association, the event will center on MD Revolution, a San Diego-based medical practice that currently uses genomic and digital technology to shift the medical paradigm from delivering reactive disease care to empowering proactive health care.
